{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:20:25Z","timestamp":1774484425378,"version":"3.50.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1097\/rlu.0000000000001777","type":"journal-article","created":{"date-parts":[[2017,7,30]],"date-time":"2017-07-30T02:30:08Z","timestamp":1501381808000},"page":"776-778","source":"Crossref","is-referenced-by-count":17,"title":["68Ga-PSMA Uptake in Neurofibromas Demonstrated on PET\/CT in a Patient With Neurofibromatosis Type 1"],"prefix":"10.1097","volume":"42","author":[{"given":"Brook","family":"Gulhane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210204","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.urolonc.2008.04.007","article-title":"PSMA expression in schwannoma: a potential clinical mimicker of metastatic prostate carcinoma","volume":"27","author":"Wang","year":"2009","journal-title":"Urol Oncol"},{"key":"R2-11-20210204","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0090-4295(00)00531-8","article-title":"Indium-111 capromab pendetide (ProstaScint) uptake in neurofibromatosis","volume":"56","author":"Khan","year":"2000","journal-title":"Urology"},{"key":"R3-11-20210204","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/RLU.0000000000001281","article-title":"Schwannoma showing avid uptake on 68Ga-PSMA-HBED-CC PET\/CT","volume":"41","author":"Kanthan","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R4-11-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00259-015-3235-y","article-title":"Intense PSMA-expression using (68)Ga-PSMA PET\/CT in a paravertebral schwannoma mimicking prostate cancer metastasis","volume":"43","author":"Rischpler","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-11-20210204","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/RLU.0000000000001384","article-title":"Prostate-specific membrane antigen PET\/CT findings for hepatic hemangioma","volume":"41","author":"Bhardwaj","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R6-11-20210204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/RLU.0000000000001460","article-title":"Intense uptake in amyloidosis of the seminal vesicles on 68Ga-PSMA PET mimicking locally advanced prostate cancer","volume":"42","author":"Stephens","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R7-11-20210204","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/RLU.0000000000000827","article-title":"Prostate-specific membrane antigen PET\/CT in splenic sarcoidosis","volume":"40","author":"Kobe","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R8-11-20210204","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00259-014-2766-y","article-title":"68Ga-PSMA PET\/CT imaging of metastatic clear cell renal cell carcinoma","volume":"41","author":"Demirci","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-11-20210204","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2967\/jnumed.115.164442","article-title":"68Ga-PSMA-HBED-CC PET for differential diagnosis of suggestive lung lesions in patients with prostate cancer","volume":"57","author":"Pyka","year":"2016","journal-title":"J Nucl Med"},{"key":"R10-11-20210204","doi-asserted-by":"crossref","first-page":"e0143305","DOI":"10.1371\/journal.pone.0143305","article-title":"Nerve sheath tumors in neurofibromatosis type 1: assessment of whole-body metabolic tumor burden using F-18-FDG PET\/CT","volume":"10","author":"Salamon","year":"2015","journal-title":"PLoS One"},{"key":"R11-11-20210204","doi-asserted-by":"crossref","first-page":"e0151809","DOI":"10.1371\/journal.pone.0151809","article-title":"Metabolic tumour burden measured by 18F-FDG PET\/CT predicts malignant transformation in patients with neurofibromatosis type-1","volume":"11","author":"Van Der Gucht","year":"2016","journal-title":"PLoS One"},{"key":"R12-11-20210204","first-page":"6162182","article-title":"The role of [18F]FDG-PET\/CT in predicting malignant transformation of plexiform neurofibromas in neurofibromatosis-1","volume":"2016","author":"Tovmassian","year":"2016","journal-title":"Int J Surg Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:19:47Z","timestamp":1620973187000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201710000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001777","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}